NASDAQ
BriaCell Therapeutics Corp. (BCTX) has a current ratio of 5.01x as of Monday, May 25, 2026. This represents a 87.80% decrease compared to its 12-month average of 41.06x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.